您的购物车当前为空
Antitumor agent-129 (Compound 68) 是一种噻唑烷-4-磺酮衍生物和骨肉瘤 (OS) 抑制剂,对 OS 细胞活性的抑制作用达到 IC50值为 0.217 μM,半衰期为 73.8 min (小鼠肝微粒体),药代动力学特征优良 (体内生物利用度 F = 115%,腹腔给药)。该化合物是 OS 研究的潜在候选药物。
Antitumor agent-129 (Compound 68) 是一种噻唑烷-4-磺酮衍生物和骨肉瘤 (OS) 抑制剂,对 OS 细胞活性的抑制作用达到 IC50值为 0.217 μM,半衰期为 73.8 min (小鼠肝微粒体),药代动力学特征优良 (体内生物利用度 F = 115%,腹腔给药)。该化合物是 OS 研究的潜在候选药物。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | Antitumor agent-129 (Compound 68) is a derivative of thiazolidine-4-thione and an inhibitor of osteosarcoma (OS), with an IC50 value of 0.217 μM against OS cell activity. It has a half-life of 73.8 minutes in mouse liver microsomes and exhibits favorable pharmacokinetic properties with an in vivo bioavailability (F) of 115% following intraperitoneal administration. Antitumor agent-129 is a potential candidate for OS research. |
| 分子式 | C20H24N4O6S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容